EpiAxis Therapeutics, A Leader in Novel Cancer Therapy, Announces the Appointment of Three New Non-Executive Directors
EpiAxis Therapeutics is a pioneering Australian pharma company that is advancing its epigenetic assets to target LSD1 as a treatment ... Read More